Bright Minds Biosciences Inc Financial Flexibility Index
Bright Minds Biosciences Inc financial flexibility index. Bright Minds Biosciences Inc (DRUG) has a Financial Flexibility Index of -3.30x as of June 2026. Free cash flow of $-8.42 Million (operating CF $-8.42 Million minus capex $0.00) represents -3% of total liabilities ($2.55 Million). See DRUG free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Bright Minds Biosciences Inc (2019–2025)
Financial flexibility index of Bright Minds Biosciences Inc from 2019 to 2025. Historical Financial Flexibility Index trend for Bright Minds Biosciences Inc across 7 annual periods. Check Bright Minds Biosciences Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Bright Minds Biosciences Inc Financial Flexibility Index by Year (2019–2025)
Bright Minds Biosciences Inc financial flexibility index by year from 2019 to 2025. Year-by-year free cash flow to debt coverage for Bright Minds Biosciences Inc. For the full cash flow conversion analysis, see Bright Minds Biosciences Inc cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.66x | $-8.69 Million | $-8.69 Million | $2.38 Million | ▼ -12.3% |
| 2024 | -3.26x | $-1.85 Million | $-1.85 Million | $568.26K | ▲ +87.0% |
| 2023 | -25.01x | $-7.02 Million | $-7.02 Million | $280.86K | ▼ -184.3% |
| 2022 | -8.80x | $-13.59 Million | $-13.59 Million | $1.54 Million | ▲ +23.2% |
| 2021 | -11.46x | $-7.32 Million | $-7.32 Million | $638.57K | ▼ -499.8% |
| 2020 | -1.91x | $-288.39K | $-288.39K | $150.92K | ▼ -67.0% |
| 2019 | -1.14x | $-42.01K | $-42.01K | $36.71K | — |